NIHON PARKERIZING (4095) FY2027 Q1 Earnings Report

Quick View

Executive Summary

Q1 of FY2027 resulted in higher revenue and earnings, with Operating Income growing substantially faster than Revenue, clearly confirming an improvement in profitability. Revenue was ¥336.7B (+5.6% YoY), Operating Income was ¥47.4B (+38.8%), Ordinary Income was ¥59.9B (+48.4%), and Net Income attributable to owners of the parent was ¥36.7B (+30.6%). The Operating Income margin rose to 14.1%, driven by the Equipment Business turning profitable and higher revenue and earnings in the Chemicals Business.

Factors Affecting Performance

【Revenue】Revenue was ¥336.7B, representing a +5.6% increase YoY. By segment, the Chemicals Business was the largest and fastest-growing business, with Revenue of ¥162.6B (48.3% of total, +8.7% YoY). The Processing Business achieved steady revenue growth, recording ¥126.9B (37.7% of total, +4.6%), while the Equipment Business was essentially flat at ¥46.6B (13.8% of total, -0.1%).

【Profit and Loss】Operating Income was ¥47.4B (+38.8%), substantially exceeding the rate of revenue growth, and the Operating Income margin improved to 14.1%. The largest contributor to earnings growth was the Equipment Business turning profitable, from an operating loss of approximately ¥1.0B in the same period last year to profit of ¥5.8B. In addition, the Chemicals Business (+16.9%) and Processing Business (+11.6%) also contributed to the increase in earnings. Ordinary Income was ¥59.9B, ¥12.5B higher than Operating Income, due to ¥13.9B in non-operating income, including dividend income of ¥4.3B, equity in earnings of affiliated companies of ¥3.5B, and foreign exchange gains of ¥1.4B. This should be evaluated separately from the growth in Operating Income. Extraordinary losses of ¥0.4B (losses on disposal and sale of fixed assets) were a minor temporary factor. After deducting income taxes and other taxes of ¥17.8B from Profit Before Tax of ¥59.5B and excluding ¥5.0B attributable to non-controlling interests, Net Income was ¥36.7B. In conclusion, the Company achieved higher revenue and earnings, with the improvement in profitability at the operating level particularly characterizing the quality of this quarter’s results.

Segment Analysis

The Chemicals Business recorded Revenue of ¥162.6B (+8.7% YoY), segment profit of ¥28.4B (+16.9%), and a profit margin of 17.5%, making it the largest contributor to consolidated earnings. The Processing Business achieved stable growth in both revenue and earnings, with Revenue of ¥126.9B (+4.6%), profit of ¥16.8B (+11.6%), and a profit margin of 13.2%. Although the Equipment Business was essentially flat in terms of Revenue at ¥46.6B (-0.1%), profit was ¥5.8B, representing a return to profitability from a loss in the same period last year (+675.2%). Its contribution to the Company-wide increase in earnings was significant. Whether the Equipment Business’s return to profitability reflects temporary factors such as project mix and cost improvements or a structural improvement will need to be assessed based on future developments.

Key Financial Indicators

【Profitability】The Operating Income margin improved to 14.1% from 10.7% in the same period last year, with operating leverage working under a structure comprising a gross margin of 36.2% and an SG&A expense ratio of 22.1%. The Net Income margin was 10.9% (based on Net Income attributable to owners of the parent), improving from 8.9% in the same period last year.【Cash Quality】Accounts receivable were ¥406.5B, accounting for 15.1% of total assets, while inventories were ¥40.3B (including ¥77.6B in raw materials; inventory-related items are susceptible to fluctuations in procurement prices for chemical manufacturing).【Investment Efficiency】ROE remained at 1.9% (quarterly basis, not annualized); even on an annualized basis, it is estimated to be in the high 6% range. Low total asset turnover and a high Equity Ratio are factors restraining the level. BPS was ¥1,921.39, up from ¥1,864.35 in the same period last year.【Financial Soundness】The Equity Ratio was extremely high at 82.7% (consolidated basis), while interest-bearing debt consisted solely of ¥2.5B in long-term borrowings, indicating low financial leverage. Cash and deposits of ¥585.5B substantially exceeded current liabilities of ¥294.5B, demonstrating strong short-term solvency.

Cash Flow Analysis

As the cash flow statement is not disclosed in this report, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥585.5B, down from ¥727.6B in the same period last year, while investment securities increased to ¥467.2B from ¥401.0B in the same period last year. This movement suggests the possibility that a portion of cash on hand was redirected toward investment in securities. Accounts receivable were ¥406.5B, slightly down from ¥422.4B in the same period last year, while accounts payable were ¥148.2B, down from ¥159.3B, indicating that changes in working capital were limited. Property, plant and equipment increased to ¥767.6B, and construction in progress of ¥89.5B accounted for 11.7% of property, plant and equipment, suggesting that ongoing capital expenditures are one source of funding requirements. Interest-bearing debt was negligible, and investment activities are considered to have been financed primarily with internal funds.

Quality of Earnings

Operating Income of ¥47.4B represents recurring profit reflecting the earning power of the core business, whereas the ¥12.5B difference from Ordinary Income of ¥59.9B resulted from ¥13.9B in non-operating income, including dividend income of ¥4.3B, equity in earnings of affiliated companies of ¥3.5B, and foreign exchange gains of ¥1.4B. This includes items with a high degree of non-recurring characteristics that are susceptible to market conditions and the performance of investee companies. Extraordinary income and losses consisted solely of an extraordinary loss of ¥0.4B (losses on disposal and sale of fixed assets), which was immaterial and had a limited impact as a temporary factor. Comprehensive income was ¥86.9B, ¥50.2B higher than Net Income of ¥36.7B, mainly due to ¥42.7B in valuation differences on securities resulting from an increase in the fair value of investment securities. This divergence reflects fluctuations in unrealized gains on shareholdings and should be viewed separately from the recurring earning power of the business. Since accounts receivable account for 15.1% of total assets, the impact of the time lag between revenue recognition and cash collection on the conversion of earnings into cash should also continue to be monitored.

Earnings Forecasts and Guidance

The full-year Company forecast calls for Revenue of ¥1,340.0B (-3.0% YoY), Operating Income of ¥150.0B (+1.3%), and Ordinary Income of ¥190.0B (-3.4%), with no revisions to either the earnings forecast or dividend forecast. Q1 progress rates were 25.1% for Revenue, 31.6% for Operating Income, and 31.5% for Ordinary Income, indicating that results are tracking above the 25% level implied by even quarterly progress. Although progress in Operating Income and Ordinary Income is ahead of schedule, attention should be paid to the fact that the full-year Revenue plan assumes a decline from the previous fiscal year. The key issue is how the gap with the revenue growth trend in Q1 will be closed going forward.

Shareholder Returns

The full-year dividend forecast is ¥50.00 per share, with no revision. Based on forecast EPS of ¥151.76, the Payout Ratio is approximately 33%, below the target level of approximately 60%. The strong financial foundation, including cash and deposits of ¥585.5B and virtually no interest-bearing debt, supports the Company’s capacity to pay dividends. The Company holds treasury shares valued at ¥286.7B (equivalent to 20.3% of shares issued), which will also be monitored as potential room for shareholder returns under its capital policy.

Risk Factors

1. Collection period for trade receivables: Accounts receivable of ¥406.5B account for 15.1% of total assets, and a lengthening collection period could affect working capital requirements and the speed at which earnings are converted into cash. The difference of ¥258.3B from accounts payable of ¥148.2B indicates the scale of funds tied up.

2. Sustainability of the Equipment Business’s return to profitability: Although Revenue in the Equipment Business was essentially flat (-0.1%), its operating result improved from a loss to profit of ¥5.8B. If this was attributable to temporary factors such as project mix or cost improvements, profit margin volatility could increase going forward.

3. Sensitivity to non-operating income and investment securities markets: Ordinary Income benefited from ¥13.9B in non-operating income, including dividend income, equity in earnings of affiliated companies, and foreign exchange gains. Fluctuations in the valuation of investment securities of ¥467.2B could affect financial indicators through Comprehensive Income and net assets.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Company’s Operating Income margin and Net Income margin substantially exceeded the industry median, positioning the Company at a high level within the industry.

Growth and Capital Efficiency

The Revenue growth rate was slightly below the industry median and remained broadly at an average level within the industry.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. Operating Income increased +38.8% against Revenue growth of +5.6%, and the Operating Income margin improved YoY. The main factors were the Equipment Business’s return to profitability and earnings growth in the Chemicals Business. Earnings growth exceeding revenue growth demonstrates the operation of operating leverage.

2. Q1 progress rates against the full-year plan were 31.6% for Operating Income and 31.5% for Ordinary Income, exceeding even quarterly progress, while the full-year Revenue plan assumes a decline from the previous fiscal year and the Company forecast remains unchanged. Consistency with progress in subsequent quarters will be a key point to monitor.

3. The financial structure, comprising cash and deposits of ¥585.5B, an Equity Ratio of 82.7%, and minimal interest-bearing debt, indicates a conservative capital structure. At the same time, the fact that accounts receivable account for 15.1% of total assets will remain an area for monitoring from the perspective of working capital efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,801–¥1,906 at ±1% in the cost of equity, and ¥1,850–¥1,854 at ±0.1 in ω.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value will be below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmark is reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a strong start, with revenue growth translating into materially faster operating and ordinary-profit growth. Revenue increased 5.6% year on year to ¥33.67bn. Operating income rose 38.8% to ¥4.74bn. Ordinary income increased 48.4% to ¥5.99bn. Profit attributable to owners of parent rose 30.6% to ¥3.67bn. Gross profit increased 13.8% to ¥12.19bn, substantially outpacing sales. The gross margin expanded 259bp year on year to 36.2% from 33.6%. The operating margin expanded 336bp to 14.1% from 10.7%. The net margin improved 208bp to 10.9% from 8.8%. SG&A expense growth was limited to 2.1%, well below the 5.6% revenue increase, demonstrating favorable operating leverage. Chemicals was the core business by segment operating-income contribution, generating ¥2.84bn of profit and accounting for 56% of aggregate segment profit before corporate-cost allocation. The equipment segment moved from a ¥0.10bn loss to a ¥0.58bn profit, providing the largest incremental improvement among the reporting segments. Ordinary income exceeded operating income by ¥1.25bn, supported by dividend income, foreign-exchange gains and equity-method earnings. The prior-year quarter included a ¥0.58bn gain on sales of investment securities, whereas the current quarter did not, supporting the underlying quality of the operating and ordinary-profit improvement. Comprehensive income was particularly strong at ¥8.69bn, aided by a ¥4.27bn positive valuation difference on securities. The balance sheet remains exceptionally liquid and lightly levered, with ¥58.55bn of cash and only ¥0.25bn of interest-bearing debt. Q1 revenue progress was in line with the full-year plan, while operating-profit progress was ahead of the normal seasonal run-rate. The principal operating item to monitor is the annualized 110-day receivables cycle, despite a year-on-year decline in receivables. The full-year forecast implies modest sales contraction but a slight increase in operating income, making preservation of the Q1 margin gain important for delivery.

Profitability Analysis

Annualized DuPont ROE was 6.6%, comprising a 10.9% net profit margin, 0.499x asset turnover and 1.21x financial leverage. The principal driver of profitability is margin strength rather than financial leverage, as the capital structure is conservatively funded. The net margin is above the 10% excellence benchmark, while annualized ROE remains below the 8% threshold because the company operates with a large equity base and modest asset turnover. Gross-margin expansion to 36.2% was the largest favorable earnings lever, rising 259bp year on year. Operating-margin expansion was even greater at 336bp, as SG&A expenses rose only 2.1% compared with 5.6% revenue growth. This indicates favorable operating leverage and suggests that the earnings growth was not merely generated by non-operating items. Chemicals remained the core business, with external revenue of ¥15.90bn, up 8.8% year on year, and segment profit of ¥2.84bn, up 16.9%. Its segment margin was 17.9%, compared with 16.6% in the prior-year quarter. Equipment revenue was broadly flat at ¥4.47bn, down 0.6%, but segment profit improved from a ¥0.10bn loss to a ¥0.58bn profit, lifting its margin to 13.0%. Processing revenue grew 3.8% to ¥12.58bn and segment profit rose 11.6% to ¥1.68bn, with margin improving to 13.4% from 12.4%. Other businesses recorded revenue of ¥0.72bn, up 10.4%, while segment profit was slightly negative at ¥0.02bn. Unallocated corporate costs increased to ¥0.47bn from ¥0.42bn, but this was more than offset by segment-level profit expansion. The tax burden was 0.617, equivalent to a 29.9% effective tax rate, and the interest burden exceeded 1.0x because non-operating income materially exceeded interest expense. Interest coverage of 2,368.5x confirms that financing costs are immaterial to earnings.

Growth Assessment

Revenue growth was led by the chemicals business, while the sharp improvement in equipment profitability broadened the sources of earnings growth. Q1 chemicals external sales increased by ¥1.29bn year on year, representing the largest absolute revenue contribution among reporting segments. Processing added ¥0.46bn of revenue, and other businesses added ¥0.07bn. Equipment sales were essentially stable, but its ¥0.68bn profit swing made it the largest contributor to incremental segment earnings. Full-year revenue guidance is ¥134.0bn, implying a 3.0% year-on-year decline, while operating income guidance of ¥15.0bn implies 1.3% growth. Q1 revenue achievement was 25.1% of the annual forecast, effectively in line with the standard 25% first-quarter progress rate. Operating-income achievement was 31.6%, 6.6 percentage points ahead of the standard first-quarter progress rate. Ordinary-income achievement was 31.5%, also ahead of a standard quarterly run-rate. Profit attributable to owners achieved 26.2% of the full-year forecast, modestly ahead of the standard rate. The full-year plan therefore appears to embed lower sales but resilient profitability, and Q1 results provide an initial cushion against that target. Dividend income of ¥0.43bn, foreign-exchange gains of ¥0.15bn and equity-method earnings of ¥0.35bn supplemented operating earnings. These items totalled less than 3% of revenue individually and do not alter the conclusion that operating-margin expansion was the dominant earnings driver. The absence of a current-period investment-security disposal gain, compared with a ¥0.58bn prior-year gain, makes the year-on-year ordinary-income growth more meaningful. Sustaining the improved equipment margin and chemicals growth will be central to maintaining the above-plan operating-profit trajectory.

Financial Health

Financial health is very strong. The current ratio was 393.1% and the quick ratio was 379.4%, indicating abundant coverage of current obligations by highly liquid assets. Current assets of ¥115.75bn exceeded current liabilities of ¥29.45bn by ¥86.31bn. Cash and deposits were ¥58.55bn, equal to almost two times current liabilities. Interest-bearing debt was only ¥0.25bn, entirely represented by long-term loans, against total equity of ¥223.14bn. Debt-to-equity was 0.21x and debt-to-capital was 0.1%, both far below conservative credit thresholds. No maturity mismatch is apparent: short-term liabilities are covered many times over by cash, receivables and other current assets, while reported borrowings are long-term. Total liabilities represented only 17.3% of total assets, and the equity ratio improved to 75.3% from 73.9% in the prior-year quarter. Interest expense was only ¥0.02bn, consistent with the very high interest-coverage ratio. Investment securities were ¥46.72bn, equivalent to 17.3% of total assets, providing a meaningful financial-asset component to the balance sheet. Deferred tax liabilities were ¥11.72bn, reflecting the relevance of unrealized valuation gains within the investment portfolio. Defined-benefit liabilities of ¥3.70bn and directors' retirement provisions of ¥0.27bn are manageable relative to the equity base. Treasury stock was ¥28.67bn, or 10.6% of total assets, and should remain relevant to per-share capital-allocation analysis.

Notable B/S Changes

Cash and deposits: -¥14.20bn (-19.5%) year on year to ¥58.55bn - liquidity remains substantial, but cash deployment was material. Investment securities: +¥6.22bn (+15.3%) year on year to ¥46.72bn - market and portfolio valuation exposure has increased. Valuation difference on securities: +¥4.17bn (+26.4%) year on year to ¥19.98bn - equity and comprehensive income are increasingly sensitive to equity-market movements. Treasury stock: -¥4.10bn (16.7% larger negative balance) year on year to -¥28.67bn - capital allocation has a material per-share effect. Current liabilities: -¥6.99bn (-19.2%) year on year to ¥29.45bn - liquidity coverage strengthened materially. Property, plant and equipment: +¥1.12bn (+1.5%) year on year to ¥76.77bn - productive asset base remained broadly stable. Construction in progress: +¥0.72bn (+8.8%) year on year to ¥8.95bn - indicates an ongoing manufacturing investment pipeline. Raw materials: +¥0.47bn (+6.5%) year on year to ¥7.76bn - inventory exposure increased ahead of the prior-year level and should be assessed alongside production demand.

Cash Flow Quality

Dividend Sustainability

The full-year dividend forecast is ¥50.00 per share and has not been revised. Against forecast EPS of ¥151.76, the implied dividend payout ratio is 32.9%. This is comfortably below the 60% sustainability benchmark and leaves a substantial earnings retention buffer. The forecast dividend is also supported by a large liquidity reserve of ¥58.55bn and negligible interest-bearing debt of ¥0.25bn. Retained earnings were ¥179.71bn, providing considerable balance-sheet capacity for shareholder distributions. The sizeable treasury-share balance of 26.9 million shares makes future buyback, cancellation or reissuance decisions potentially relevant to per-share outcomes. The stated dividend level appears conservatively aligned with forecast profitability and capitalization.

Risk Assessment

Business risks include Chemical-manufacturing demand is exposed to automotive, industrial-production and broader capital-spending cycles; the full-year sales plan already assumes a 3.0% year-on-year revenue decline., The equipment business recorded a substantial Q1 profit recovery despite slightly lower revenue; maintaining a 13.0% segment margin will be important because this improvement may be sensitive to project mix, execution and fixed-cost absorption., Chemical operations face raw-material, energy-cost, environmental-compliance and product-quality risks that can pressure gross margins., Foreign-exchange movements remain relevant to reported earnings: Q1 included ¥0.15bn of FX gains, while international operations and foreign-currency translation reserves remain material..

Financial risks include The investment-security portfolio of ¥46.72bn, or 17.3% of assets, creates exposure to market-value movements; the ¥4.27bn positive securities valuation gain was a major contributor to comprehensive income., Receivables were ¥40.65bn and the annualized DSO was 110 days, exceeding the 60-day warning threshold. The elevated collection cycle increases working-capital intensity and potential customer-credit exposure., Treasury stock increased by ¥4.10bn year on year to ¥28.67bn, which can enhance per-share metrics but also represents a meaningful allocation of capital..

Key concerns include HIGH_RECEIVABLE_DAYS: Annualized DSO of 110 days is the principal quality alert. It indicates that revenue is converted into customer receivables relatively slowly for a manufacturing benchmark, potentially raising cash-conversion and counterparty-credit risk. The context is somewhat constructive because accounts receivable declined 3.8% year on year while sales increased 5.6%, but the absolute collection period remains elevated and warrants monitoring., Forecast execution risk is concentrated in preserving margin gains: Q1 operating margin of 14.1% is well above the full-year implied operating margin of 11.2%., Comprehensive income is more market-sensitive than net income because accumulated other comprehensive income includes sizable valuation and translation adjustments..

Investment Implications

Key takeaways include Q1 operating income growth of 38.8% materially exceeded 5.6% revenue growth, driven by gross-margin expansion and restrained SG&A growth., Chemicals is the core earnings business, while equipment's swing from loss to profit was the largest source of incremental segment profit., Q1 operating-income progress reached 31.6% of full-year guidance, ahead of the standard 25% first-quarter run-rate., The company has an unusually strong balance sheet, with a 393.1% current ratio, 75.3% equity ratio and only ¥0.25bn of interest-bearing debt., The implied 32.9% dividend payout ratio is conservative relative to forecast earnings..

Metrics to watch include Annualized DSO and the level of trade receivables, Chemicals segment revenue growth and segment margin, Equipment segment margin durability and project execution, Gross margin and SG&A-to-sales ratio, Progress toward ¥15.0bn full-year operating-income guidance, Market-value changes in the ¥46.72bn investment-security portfolio, Treasury-share movements and their effect on per-share capital allocation.

Regarding relative positioning, Profitability is strong on a margin basis, with a 14.1% operating margin near the upper end of the stated good range and a 10.9% net margin above the excellence benchmark. Annualized ROE of 6.6% is comparatively modest, primarily because the company maintains a very large equity base and low leverage rather than because of weak earnings margins. Liquidity and solvency are materially stronger than conventional manufacturing credit benchmarks, while the 110-day receivables cycle is the principal operating-efficiency weakness.